Lv5
1570 积分 2023-03-17 加入
Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
18小时前
已完结
Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders
6个月前
已完结
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1
7个月前
已完结
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors
7个月前
已完结
Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985)
8个月前
已完结
DS-8201a, a new HER2-targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance
8个月前
已完结
Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma
10个月前
已完结
TSPAN8+ myofibroblastic cancer-associated fibroblasts promote chemoresistance in patients with breast cancer
11个月前
已完结
Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma
1年前
已完结
Five decades of advances in cancer research
1年前
已完结
皖公网安备34019202002308
